A retrospective study in Chinese patients: Is there a role of nanoparticle albumin bound paclitaxel in advanced NSCLC?

被引：0
|
作者：
Zhu, Y. [1 ,2 ]
Xing, P. [1 ,2 ]
Shan, L. [3 ]
Chen, S. [4 ]
Hao, X. [1 ,2 ]
Li, J. [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Med Oncol Canc Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Shanghai Med Univ, Canc Hosp, Shanghai, Peoples R China
[4] Capital Med Univ, Bejing Tongren Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
123P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China
    Xing, Puyuan
    Zhu, Yixiang
    Shan, Ling
    Chen, Sipeng
    Hao, Xuezhi
    Li, Junling
    [J]. ONCOTARGET, 2017, 8 (50) : 87442 - 87454
  • [2] ECONOMIC EVALUATION OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR PREVIOUSLY TREATED ADVANCED NSCLC IN JAPAN
    Fukui, Y.
    Chen, W.
    Maeda, T.
    Morimoto, K.
    Moriwaki, K.
    Shimozuma, K.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S150 - S150
  • [3] A tolerability study of a cremophor free, nanoparticle albumin bound paclitaxel intravenously administered in Chinese patients with advanced solid tumor.
    Teng, X
    Guan, Z
    Yao, Z
    Liu, D
    Zhou, N
    Luo, H
    Hawkins, MJ
    Soon-Shiong, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 517S - 517S
  • [4] A Retrospective Analysis Of Nanoparticle Albumin Bound Paclitaxel In Chinese Patients With Recurrent Advanced Non-small Cell Lung Cancer In A Single Center
    Zhu, Yixiang
    Xing, Puyuan
    Chen, Sipeng
    Li, Junling
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S899 - S900
  • [5] Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study
    Liu, Yang
    Dong, Yinping
    Zhu, Hui
    Jing, Wang
    Guo, Hongbo
    Yu, Jinming
    [J]. CANCER MEDICINE, 2020, 9 (04): : 1365 - 1373
  • [6] Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC
    Yoneshima, Yasuto
    Morita, Satoshi
    Ando, Masahiko
    Nakamura, Atsushi
    Iwasawa, Shunichiro
    Yoshioka, Hiroshige
    Goto, Yasuhiro
    Takeshita, Masafumi
    Harada, Toshiyuki
    Hirano, Katsuya
    Oguri, Tetsuya
    Kondo, Masashi
    Miura, Satoru
    Hosomi, Yukio
    Kato, Terufumi
    Kubo, Toshio
    Kishimoto, Junji
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Okamoto, Isamu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (09) : 1523 - 1532
  • [7] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Okunaka, Mashiro
    Kotani, Daisuke
    Demachi, Ken
    Kawazoe, Akihito
    Yoshino, Takayuki
    Kawasaki, Toshikatsu
    Shitara, Kohei
    [J]. BMC CANCER, 2020, 20 (01)
  • [8] THE ROLE OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL (NAB-P) IN THE NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS
    Kavvadias, Alexandros
    Charpidou, Andriani G.
    Gkiozos, Ioannis
    Syrigos, Kostas N.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1256 - S1257
  • [9] Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
    Mashiro Okunaka
    Daisuke Kotani
    Ken Demachi
    Akihito Kawazoe
    Takayuki Yoshino
    Toshikatsu Kawasaki
    Kohei Shitara
    [J]. BMC Cancer, 20
  • [10] Myelosuppression Caused by Nanoparticle Albumin-Bound Paclitaxel in the Northern Chinese Population and the Role of Body Composition
    Shi, Yongzhi
    Guo, Jiayuan
    Jiang, Ying
    Zhao, Juan
    Li, Jiaxuan
    Shen, Jing
    Jin, Gaowa
    Bai, Xiaojun
    Li, Quanfu
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (09): : 1009 - 1016
12345